Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 2
1992 1
1993 1
1997 1
1998 2
1999 3
2000 2
2001 1
2004 2
2006 3
2007 1
2008 2
2011 2
2012 1
2013 5
2014 1
2015 2
2016 5
2017 6
2018 7
2019 4
2020 1
2021 10
2022 7
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.
Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S, Frigo AC, Giusti P, Moro S. Zusso M, et al. J Neuroinflammation. 2019 Jul 18;16(1):148. doi: 10.1186/s12974-019-1538-9. J Neuroinflammation. 2019. PMID: 31319868 Free PMC article. Review.
The effect of CPFX and LVFX on LPS-induced release of IL-1beta and TNF-alpha and NF-kappaB activation was investigated in primary microglia by ELISA and fluorescence staining. The interaction of CPFX and LVFX with TLR4-MD-2 complex was assessed by immunoprecipitation follo …
The effect of CPFX and LVFX on LPS-induced release of IL-1beta and TNF-alpha and NF-kappaB activation was investigated in primary microglia …
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku'ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW. Welsh JA, et al. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. J Extracell Vesicles. 2024. PMID: 38326288 Free PMC article.
The burden of the knowledge-to-action gap in acute appendicitis.
Cioffi SPB, Altomare M, Podda M, Spota A, Granieri S, Reitano E, Zamburlini B, Virdis F, Bini R, Gupta S, Torzilli G, Mingoli A, Chiara O, Cimbanassi S; REsiDENT-1 research group. Cioffi SPB, et al. Surg Endosc. 2023 Dec;37(12):9617-9632. doi: 10.1007/s00464-023-10449-4. Epub 2023 Oct 26. Surg Endosc. 2023. PMID: 37884735 Free PMC article.
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Chebani R, Lombart F, Chaby G, Dadban A, Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C, Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F, Prost-Squarcioni C, Grootenboer-Mignot S, Alexandre M; French Study Group on Autoimmune Bullous Diseases. Chebani R, et al. Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369. Br J Dermatol. 2024. PMID: 37792727
The criteria for clinical response to omalizumab were defined according to the 2012 international consensus conference. Anti-BP180-NC16A IgE enzyme-linked immunosorbent assay was performed on sera collected before initiating omalizumab, when available. …
The criteria for clinical response to omalizumab were defined according to the 2012 international consensus conference. Anti-BP180-NC16A IgE …
Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.
Cogo S, Tomkins JE, Vavouraki N, Giusti V, Forcellato F, Franchin C, Tessari I, Arrigoni G, Cendron L, Manzoni C, Civiero L, Lewis PA, Greggio E. Cogo S, et al. Neurobiol Dis. 2022 Nov;174:105858. doi: 10.1016/j.nbd.2022.105858. Epub 2022 Sep 9. Neurobiol Dis. 2022. PMID: 36096339 Free article.
74 results